Firm at a glance
New Harbor Capital is a platform private equity firm headquartered in Chicago, IL, per its own website [S1].
What they buy
New Harbor Capital’s portfolio demonstrates a concentration in healthcare services and education businesses, per publicly disclosed investments [S2]. The firm appears to pursue platform acquisitions in fragmented service sectors, with observable activity in behavioral health, physical therapy, ophthalmology, pain management, and educational technology [S2][S3]. The portfolio pattern suggests interest in businesses that can be scaled through add-on acquisitions and operational improvements in professional services markets.
Portfolio
Healthcare
New Harbor Capital’s healthcare portfolio includes Community Psychiatry Management (acquired July 2015 as a platform) [S3], PT Solutions, LGM Pharma, Suture Express [S2][S4], Ocean State Healthcare, KURE Pain Management, and Quigley Eye Specialists [S3]. The concentration of healthcare service providers suggests this is a core sector focus for the firm.
Education and Education Technology
The firm’s education investments include Blueprint Prep and Certica Solutions [S2][S3], representing both test preparation and educational technology subsectors.
Recent activity (last 24 months)
No recent public transactions were surfaced in the available data for the 24 months preceding January 2025.
How this firm fits a seller
New Harbor Capital appears positioned for healthcare and education service businesses seeking a platform buyer with sector experience. The firm’s portfolio composition suggests familiarity with professional services models, particularly in healthcare verticals such as behavioral health, physical therapy, and specialty medical practices [S2][S3]. For owner-operators in these sectors, the firm’s track record indicates experience managing multi-location service businesses. The absence of recent publicly disclosed transactions may reflect either a focus on portfolio company development or private deal activity not captured in public sources.
Sources
[S1] https://newharborcap.com/who-we-are/ (as of 2025-01-10)
[S2] https://newharborcap.com (as of 2025-01-10)
[S3] https://newharborcap.com/investments/community-psychiatry-management/ (as of 2025-01-10)
[S4] https://newharborcap.com/who-we-are/ (as of 2025-01-10)
Frequently asked questions
Does New Harbor Capital buy Healthcare businesses?
Yes, healthcare represents the majority of New Harbor Capital’s publicly disclosed portfolio, per its website [S2]. The firm has invested in behavioral health, physical therapy, ophthalmology, pain management, pharmaceutical services, and medical supply businesses [S2][S3], indicating substantial experience in healthcare services sectors.
What companies has New Harbor Capital acquired recently?
The most recent publicly disclosed acquisition with a date is Community Psychiatry Management, acquired in July 2015 as a platform investment [S3]. Other portfolio companies including PT Solutions, LGM Pharma, and Blueprint Prep are listed on the firm’s website without specific acquisition dates [S2].
Where is New Harbor Capital based and how big is the firm?
New Harbor Capital is based in Chicago, IL, with its office located in that city [S1][S2]. Fund size and assets under management are not publicly disclosed in available sources as of January 2025.
Is New Harbor Capital still actively acquiring?
The firm maintains an active website with portfolio company listings as of January 2025 [S2], though no transactions from the most recent 24 months were identified in publicly available sources. Prospective sellers should contact the firm directly to confirm current acquisition activity and investment criteria.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.